SYMPOSIUM 3RD MYVET HOSPITAL GROUP - MAKARANGA LODGE 09 FEBRUARY 2020 - INANDA VETS
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
VETERINARY SYMPOSIUM 2020 3rd MyVet Hospital Group Symposium Makaranga Lodge 09 February 2020 Editors: Dr Anthony Zambelli & Ms Amanda Shaw Master of Ceremonies: Dr Kenneth Joubert 1
VETERINARY SYMPOSIUM 2020 Dear Colleagues, Welcome to our third annual veterinary symposium. My team of dedicated staff, led by Ms Amanda Shaw, has assembled a useful, coherent and I am sure you will find, enjoyable series of “upskills” for all attendees. Every year we analyse the feedback you give us, to select topics that you want to learn about. There’s obviously more than we can cover in one day, so the choices are very difficult. This year we have chosen to focus on the head, neck, skin and endocrinology – both medical and surgical. Dr Kenneth Joubert will be our MC this year, guiding us through the topics of the day, and welcoming a new speaker – Dr Sara Boyd, a specialist surgeon with over two decades of experience – who has joined our group. We remain, as ever, dedicated as a group, and with our visiting consultants, to assisting your practice to extend your service and veterinary capabilities. Any practice in KZN should be able offer its clients and patients some hope, help or treatment, that is already available to humans – even without hiring new staff or investing in expensive equipment. We are here to be an extension of your practice, and we strive to constantly improve our service offering to you, and with you. The veterinary healthcare industry in SA is under enormous stress at the moment, as well as having increasingly demanding clients presenting us with a progressively first-world (aging) pet population with more chronic illnesses, as well as some local combinations such as infectious diseases and skin cancer. We must rise to these challenges using the skills and tools available to us. Our corporate sponsors make this sort of learning opportunity possible, provide aftercare and tech support, and the products we use, to achieve our goals – they make us more versatile, flexible and responsive to our pets’ needs. Please thank the representatives of Royal Canin, Virbac, Zoetis and IDEXX when you see them, and interact with their staff on the day, to understand how vets and our support industries can work together. I particularly want to thank Ms Shaw for months of planning and effort, without which this would not be possible; Dr Joubert for chairing the sessions; Drs Greenberg, Pimosenco, Ruiz and Boyd, for their time spent on developing lectures and notes; my staff for assisting on the day; Makaranga Lodge for hosting us yet again; and all of you for supporting us, working with us, telling us what you need, and helping us grow from a small practice of 6, to a group of over 50 staff. We look forward to many years collaboration for the betterment of all our mutual clients, our profession and the pet healthcare industry. Welcome, with sincere thanks Anthony Zambelli Director, MyVet Hospital Group Inanda Veterinary Specialist Centre 2
VETERINARY SYMPOSIUM 2020 Agenda 09.00 - 9.30am - Arrival and Registration “Practical Tips and Techniques for Surgery of the Head: Ear, Nose and Throat” – pg 9 Dr Sara Boyd “Oral Tumours: From diagnosis to Treatment. What to Expect.” – pg 17 Dr Jose Ruiz ~Tea~ “Secrets to Success in Dermatology”– pg 33 Dr Anthony Zambelli “Case Based Approach to Endocrine Conditions” – pg 51 Dr Arina Pimosenco Royal Canin’s Gastrointestinal Range: What to Use and When Dr Michelle Harman ~Lunch~ “Canine Behaviour Disorders Influenced by Owners & Environment” – pg 63 Dr Melvyn Greenberg “How Do We Become the Best Vet/Vet Nurse We Can be?” – pg 67 Dr Kenneth Joubert 16.05pm – Closing 3
VETERINARY SYMPOSIUM 2020 Speakers Dr. Sara Boyd BVsc MMedVet (Surgery) Sara was born and grew up in Johannesburg, South Africa. She graduated in 1997 from Onderstepoort Veterinary Faculty with a BVSc. After working in the UK for 2 years, she returned to Onderstepoort as a surgical resident and later, a senior lecturer. She completed her MMVedVet degree in April 2004. She has been an owner and partner in Johannesburg Specialist Veterinary Centre for the past 20 years, prior to going on her own as a consulting Specialist Small Animal Surgeon. Sara is involved in presenting CPD courses both in South Africa and abroad. Her special interests lie in the field of soft tissue and neurosurgery. She remains proficient in the field of Orthopaedics and is one of the few South African surgeons regularly performing TPLO and Canine Cementless Total Hip Replacement. She is married to Mark Boyd and has 3 children. Dr. José Carlos Almansa Ruiz DVM (Hons) MSc (Vet), Resident, Veterinary Dentistry Member of the Royal College of Veterinary Surgeons José is originally from Spain. He qualified from the Universidad Complutense de Madrid in 2008. Thereafter he completed his honours degree in dentistry and maxillofacial surgery while working in a busy afterhours hospital in Madrid. In 2009, he relocated to Pretoria where he undertook an internship in dentistry and maxillofacial surgery under Prof. Gerhard Steenkamp for 18 months, while concurrently undertaking an MSc degree. In 2011, he relocated to the UK where he worked in the greater London area working as a general practitioner and getting referrals in dentistry and maxillofacial surgery from Kent and Surrey areas. In 2012, he started his European Diploma in Veterinary dentistry through the alternative pathway under the supervision of Dr. Lisa Milella, for which he is hoping to submit his credentials in this year. In 2014 he completed the AOVET Course-Masters in Operative Treatment of Craniomaxillofacial Trauma and Reconstruction. In 2015, he moved back to South Africa, this time to Cape Town, where he joined Tygerberg Animal Hospital as a veterinarian with a special interest in Dentistry and Maxillofacial surgery. At the beginning of 2017 he moved back to Pretoria where he joined VetDentSA. He is a consultant for Inanda Veterinary Hospital in Durban and Tygerberg Animal Hospital in Cape Town. José has a special interest in Wildlife Dentistry and Maxillofacial surgery where he is an active researcher. He has presented in national and international congresses. 5
VETERINARY SYMPOSIUM 2020 Dr. Kenneth Joubert BVSc MMed Vet (Anaes) Kenneth graduated with a BVSc from The University of Pretoria in 1995. After graduating he joined small animal practice in Johannesburg for 2 years before returning to the University of Pretoria. In 2000 he obtained a MMedVet (Anaes) and held the position of senior lecturer in anaesthesiology at the university. In 2004 he left the university to re-join private practice before starting his own referral practice in anaesthesiology, pain management and critical care. Kenneth has published 37 scientific publications, delivered 80 scientific presentations, delivered 142 continuing education talks, done 14 multimedia presentations, published 39 non-scientific articles, presented 7 course, written one book chapter and attended 66 congress of continuing education. Kenneth currently holds an extra-ordinary lecturing post in Pharmacology in the department of Paraclinical Sciences at the University of Pretoria and runs a private practice dedicated to anaesthesia, analgesia and intensive care. He has regularly examined students in pharmacology, anaesthesiology and clinical studies. Kenneth has and is currently involved in the supervision of 4 students. Kenneth has a keen interest in total intravenous anaesthesia, intensive care, ventilation and cardiology. His research interests included non-steroidal anti-inflammatory agents, anaesthetic depth monitoring and total intra- venous anaesthesia. Kenneth chaired the Faculty Ethics Committee (Animal Use and Care Committee) until it was dissolved to form a University based Animal Use and Care Committee. I was then a member of the Senate committee for Research Ethics and Integrity and the Animal Use and Care Committee of the University of Pretoria. Kenneth currently serves on the AUCC (RECA) Nelson Mandela Metropolitan University and the Ethical Review Group of the AVA. He is also a member of the Education Committee and the Standard Committee of the South African Veterinary Council. In 2019 he joined Inanda Veterinary Hospital. Dr. Arina Pimosenco DVM cum laude BVSc(Hons) Arina qualified as a veterinary surgeon cum laude in 2007 in Eastern Europe. She has worked in Johannesburg suburbs mostly with small animals from 2009 to 2016. She also completed her Honours Degree in Veterinary Medicine, Clinical Pathology and Radiology in 2014 from Onderstepoort. Arina likes challenging diagnostics and endless opportunities of veterinary medicine to help our furry family members. She joined Inanda Veterinary team in May 2016 and has been privileged to work for Veterinary Medicine Specialist Dr Anthony Zambelli, where she continues professional development in the veterinary field of choice. Arina is currently doing Advanced Practitioner course in Small Animal Medicine with European School of Veterinary Postgraduate Studies (ESVPS) and Harper Adams University in UK. 6
VETERINARY SYMPOSIUM 2020 Dr. Melvyn Greenberg BVSc Melvyn Qualified with B.V.Sc. at Onderstepoort in1973, receiving the Pfizer Clinics Prize in final year. He has been a Small animal private practitioner since January 1974 with a special interest in animal behaviour from the outset. He received the Boswell Award from the SAVA in 1995 and the Rick Massey Trophy from the Witwatersrand Branch of the SAVA in 1999 for outstanding service to the veterinary profession, and he co-founded the Animal Behaviour Consultants Group in 1994 due to the plethora of behaviour disorders amongst pets, hoping that all qualifying consultants “talk the same language”. He also hosted a Pet Care line, initially as Capitol Vet on Capitol Radio, then as Dr Platzhund on Radio 702 (and later Cape talk) over a period of 22 years – borne, initially, out of the need to advise the public on how to prevent dogs from biting people. He was the first veterinarian to conduct puppy socialisation classes at the veterinary practice level, and then helped promote it nationwide. He is the author of Dr Platzhund’s Pet Pointers, published in 1998 containing close to two dozen common pet-related problems but has also written thousands of articles in hundreds of local and national printed media, on behaviour issues, over 33 years He has been an invited guest on animal related issues on many television programmes throughout the country which included a personal 13 -episode series The Creature Feature. He was an expert witness in 18 serious court cases involving canine aggression causing human injury, mutilation or death, and was initially a resident advisor to Mutual & Federal and then to the legal fraternity at large. Dr. Anthony Zambelli BSc(Hons) BVSc DiplSnrMgmt MMedVet(Med) (cum laude) Anthony qualified as a vet in 1998, concurrently completing the intercalated honours degree in Zoology from Wits in 1995. After 5 years in private practice in the UK, during which time he completed the fast-track MBA certificate and diploma courses in senior management through the Open University, he returned to SA to undertake specialist training and a lectureship at OP. He completed his MMedVet(Med) in 2006, graduating cum laude in 2008. He started in private practice in 2006, before branching out to start up Inanda Vets in 2011. With Dan Ohad and Remo Lobetti he completed a long term study in Boerboel Cardiomyopathy, as well as a study on hypertriglyceridaemia in Miniature Schnauzers. He is currently a student of UNISA, in his 4th year of a degree in Chemistry and Archaeology. 7
VETERINARY SYMPOSIUM 2020 Practical Tips and Techniques for Surgery of the Head: Ear, Nose and Throat Dr Sara Boyd BVSc MMed Vet (Surgery) INTRODUCTION Surgery of the “head” is a very wide based topic, however it encompasses commonly presenting conditions, many of which can be adequately addressed in a general practice type set-up. The aim of this talk is to try and provide some practical treatment tips for these cases; it will cover the principles of surgical ear techniques that are available, surgery of the external nasal passages and surgery of the oral cavity and soft tissues of throat. Oral tumours and their treatment does not fall within the scope of this talk and is addressed as a separate topic in this symposium. Ear A large number of conditions that affect the ear do not require surgical intervention; however, surgery may be required in the presence of severe recurrent ear disease that is refractory to medical treatment, if condition involves neoplasia or if owner compliance is lacking. End stage ear canals often require surgical intervention and three surgical procedures have been well described in the definitive treatment of Otitis Externa (OE) in both dogs and cats. The aim of all of them is similar: to remove the source of the infection and to improve ventilation and drainage of the ear canal. Surgical anatomy: The external ear canal is a cartilage tube that extends from the external auditory meatus on the skull to the external pinnae. It consists of a short vertical canal and a slightly longer horizontal canal which ends at the tympanic membrane. It is lined by epithelium that is continuous with FIGURE 1. SCHEMATIC DIAGRAM OF THE SKULL ANATOMY AND the skin and therefore TYMPANIC BULLA OF THE DOG 9
VETERINARY SYMPOSIUM 2020 prone to the same conditions and allergies that the skin suffers from. The tympanic bulla or middle ear lies on the medial aspect of the ear drum and contains the auditory ossicles. It also has the sympathetic nerve running through it and the hypoglossal nerve and external carotid artery running directly ventral to it. The facial nerve runs just caudal and ventral to the external auditory meatus and is very prone to injury during surgery, especially with chronic ear disease. The last structure that may be damaged during surgery is the Retroglenoid vein which lies rostral to the tympanic bulla. This causes significant haemorrhage at the time of surgery but has no long term ill-effects. In cats the tympanic bulla has two distinct compartments, a larger ventro- medial one and a smaller dorso-lateral one. The medial portion of the ear canal is the inner ear which lies in the petrous part of the temporal bone. When this is affected more serious clinical and vestibular neurological signs may be present. The most commonly executed surgical procedures for the treatment of chronic Otitis Externa and media include: a lateral ear canal ablation, vertical ear canal ablation, ventral bulla osteotomy (VBO) and lastly a total ear canal ablation (TECA) together with a lateral bulla osteotomy (LBO). This is fondly known as a TECABO! Lateral Ear Canal Resection: This is the resection of the lateral wall of the vertical ear canal in order to facilitate air flow and drainage and allow better access to the rest of the ear canal for topical treatment applications. The modified version where a cartilage drainage plate is created to prevent hair growth around the opening is known as the Zepp’s procedure. The procedure, although popular is rarely successful as it often fails to remove the underlying cause. One exception to this is in the presence of an isolated lesion on the lateral wall of the vertical canal. Vertical Ear Canal Ablation: This is similar to the above procedure but requires dissection and resection of the entire vertical canal. Again, its indications are limited to those conditions that only affect the vertical canal. It does create a much better cosmetic appearance than that of a lateral wall resection. Ventral Bulla Osteotomy: This procedure is designed to provide drainage at the most ventral portion of the tympanic bulla. The indications are for primary conditions of the middle ear where an intact ear drum and a normal external ear canal exist and for failed TECA procedures. It requires technically difficult dissection, especially in the dog. In cats is the procedure of choice for removing inflammatory polyps and the entire lining of the tympanic bulla. Total Ear Canal Ablation and Lateral Bulla Osteotomy: This is a salvage procedure, but is by far the most effective surgical treatment for end-stage ear canal disease. End stage ear canals have the following characteristics: hyperplasia of the epithelium, hypertrophy of the glands, collapse and/or stenosis of the horizontal part of the ear canal, calcification of the peri-auricular soft tissue. Many of these cases also have a ruptured tympanic membrane and concurrent otitis media. By removing the entire lining of both the external ear canal and the tympanic bulla, TECA/LBO provides a definitive cure for these animals. It is however a complicated procedure with serious 10
VETERINARY SYMPOSIUM 2020 potential complications if it is performed by someone who is not totally familiar with the anatomy of this area. Described complications of this surgical procedure include: fascial nerve palsy, vestibular syndrome, Horner’s syndrome (in cats), chronic recurrent draining sinus tracts and poor carriage of the external pinnae. Nose Many of the nasal and oral issues mentioned above: fall under the category of Upper Airway Obstruction Syndrome (UAOS) or Brachycephalic Airway Syndrome (BAS) and refers to a combination of problems causing partial or complete obstruction to the upper airway. Breeds commonly affected include: English and French Bulldogs, Boxers, Boston Terriers, Pug and Staffordshire Bull Terriers. These breeds all have the typically compressed face characterised by an inherited developmental defect where facial bones grow to normal width, but reduced length. The soft tissues of the head are not proportionately reduced and are often even redundant. The components of BAS include: stenotic nares, elongated soft palate, everted laryngeal saccules and tracheal hypoplasia. Stenotic nares are visually apparent and easy to diagnose. Observing the external openings during inspiration, we can clearly see whether there is paradoxical closure as the animal inspires. Sneezing, inspiratory stridors or mucopurulent discharges are further clues to stenotic nares. Other causes of nasal obstruction include traumatic, neoplastic, foreign body inhalation or infectious causes of nasal disease. Stenotic nares are found frequently in Brachycephalic breeds. Although a minor component of the syndrome, having insufficient external passage for air causes animals to open-mouth breathe and increases respiratory flow rates through the rest of the airway. The surgical repair is not technically demanding, it consists of performing bilateral wedge naroplasties. It is important that these wedges are sufficiently deep to open the nares at least 7-10mm into the nasal passages. Fine absorbable suture material is used to close the defects and haemorrhage is usually easily controlled. Mouth and Lip Surgery Many simple reconstructive techniques are available to repair (sometimes substantial) defects to the nasal and lip region. Resection of tumours is another prime indication for these types of procedures. Techniques used may be as simple as accurate anatomical reconstruction or as complicated as lip to lid transposition flaps. During the presentation, a variety of clinical cases will be used to demonstrate the techniques. At all times it must be remembered that the lips and mouth are a highly mobile structures and adequate tension relieving techniques are essential to their success. On the upside: these oral cavity of blessed with a prolific blood supply, so healing is fast and patient morbidity low. 11
VETERINARY SYMPOSIUM 2020 Throat Staphylectomy is the resection of an elongated soft palate. This is performed via an oral approach and aims to remove excessive tissue so that the obstruction to the dorsal glottis is removed. The excessive tissue is clamped and sharply resected. A monofilament absorbable suture material in a continuous pattern is used to close the defect. Intraoperative haemorrhage and oedema, as well as the post-operative risks of dog developing obstruction from the surgery are further causes for concern. More advanced techniques for resection using laser excision has been performed successfully, however the equipment needed is expensive and not readily available. Further upper airway obstruction can be caused by eversion of the laryngeal ventricles into the opening of the glottis. These ventricles are mucosal diverticulae that are situated rostal and lateral to the vocal folds. When excessive negative pressure is experienced within the upper airway, these ventricles tend to evert towards the midline and become extremely oedematous. They then block the lower half of the airway at the level of the laryngeal glottis. Many affected animals have a combination of the above conditions which can lead to a decrease in glottis aperture of as much as 80 to 90%. Surgical correction is straight forward resection of the distal saccules, which is only hindered by difficulty with visualisation due to caudal position and presence of an ET tube. Stabilising the patient in respiratory distress The classic signs of acute respiratory distress include open mouth, laboured breathing, cyanosis, abducted forelimbs, restlessness and even collapse. Animals exhibiting these signs should be handled with care so as not to compromise them any further. Removing them from their distressed owners and taking them to a cool, quiet environment where oxygen supplementation can be administered, is the first important step. Supplementary oxygen can be started immediately. Concurrent hyperthermia is common and cooling techniques including icepacks in the axilla, inguinal area or on the extremities or surrounding the IV line should be employed. Wetting the animal and directing an electric fan on them, may also help to bring the body temperature back to normal. Before physical examination is possible, the dog may require a sedative like Buprenorphine and possibly even treatment with a short acting, IV corticosteroid. They should be allowed to remain unrestrained and, in the position that they find most comfortable. In more severe cases, where laryngeal oedema has developed, the veterinarian may have to consider endotracheal intubation or even an emergency tracheostomy. IV fluid administration is not usually necessary in the immediate stabilisation and care should be taken, if administered, not to overhydrate the already compromised lungs. Establishing the cause of the respiratory distress By assessing the abnormal respiratory sounds at various levels, we can gain clues as to the underlying origin of the obstruction. It is important to note at his point that 12
VETERINARY SYMPOSIUM 2020 animals should never make a noise when breathing. Even young animals which present with noisy breathing, must have some form of obstruction. This should be recognised by veterinarians and corrected as early as possible. Gentle pressure over the laryngeal area often exacerbates respiratory compromise at the level of the larynx. Auscultation is useful for localizing the obstruction to this region. A characteristic inspiratory stertor, is a common finding in laryngeal obstruction cases. Once the problem has been isolated to the larynx, survey radiographs of the laryngeal region are useful and should accompany the standard views of the thoracic cavity. Routinely, radiographs are followed by a full visual examination of the laryngeal region with the animal lightly anaesthetised. This helps differentiate laryngeal paralysis from laryngeal collapse, elongated soft palate or everted laryngeal ventricles. Visual examination of the upper airway These patients are considered anaesthetic risks and every precaution should be taken to make sure that they survive the initial diagnostic procedures. Laryngeal function can be inhibited by certain drugs and these should be avoided if an accurate assessment of laryngeal function is to be made. Preoxygenation of affected dogs for 3-5 minutes with 100% oxygen prior to induction can significantly decrease risks. Propofol is generally used as the author’s induction agent of choice, as it has the advantage of having a very short half-life. The animal should only be anaesthetised to the level where the tongue can be retracted, but the swallowing mechanism is not affected. Tongue should not be pulled too forcefully, as this can give a false under-estimation of the length of the soft palate. Endotracheal tubes and oxygen supplementation are always on hand and in case blood oxygen saturation levels cannot be maintained. An accurate light source and a long tongue depressor or laryngoscope is required in order to assess the length of the soft palate in relation to the tip of the epiglottis. The normal guideline is that a 1-3 mm overlap is acceptable. In the case of an elongated soft palate, there may be as much as a 12-20mm overlap. In English Bulldogs, this redundant soft palate tissue may also be exceedingly thick. The soft palate should then be elevated to visualise the entrance to the glottis. This allows the relationship between the corniculate and cuneiform processes of the arytenoid cartilages to be assessed. Any contact or overlap between them, may indicate a degree of concurrent laryngeal collapse. During inspiration, it is important to establish whether the vocal cords are abducting appropriately. In the case of laryngeal paralysis, the vocal folds cannot be adequately abducted and so they obstruct the laryngeal glottis. This exacerbates the negative pressure within the airway and leads to a vicious cycle of respiratory obstruction and eventually upper airway collapse. A useful aid in confirming whether paralysis is present or not, is to inject the animal with Doxapram (Dopram) at a dose of 0.5-2 mg/kg IV whilst observing the vocal folds for movement. The increased respiratory effort that occurs when Dopram is given, makes it easier to see whether there is adequate abduction and exacerbates paradoxical movement. 13
VETERINARY SYMPOSIUM 2020 If all of the above structures appear within normal limits and no obvious cause for the respiratory obstruction can be identified, then endoscopy of the trachea and bronchi is indicated. CONCLUSION Surgery of the head is one of the few places where simple techniques and unsophisticated equipment can be used in first opinion practices to significantly improve outcomes. The golden rules are that surgeons make a correct diagnosis, understand the aim of the technique and follow sound surgical principles in the correction of the initial condition. REFERENCES 1. Fossum TW. Surgery of the upper respiratory system. In: Fossum TW. Small Animal Surgery (4th). Missouri: Elsevier Mosby:2013: 906-957. 2. Fasanella FJ, Shivley JM, Wardlaw JL et al. Brachycephalic airway obstructive syndrome in dogs: 90 cases (1991-2008). J Am Vet Med Assoc 2010;237:1048. 3. Hedlund CS. Surgical management of brachycephalic syndrome. In: Bojrab MJ. Current Techniques in Small Animal Surgery (4th): Pennsylvania: Williams and Wilkens: 1998: 357-376. 4. Poncet CM, Dupre GP, Freiche VG, et al. Long term results of upper respiratory syndrome: surgery and gastrointestinal tract medical therapy in 51 brachycephalic dogs. J Small Anim Pract 2006;47:137. 5. Riecks TW, Birchard SJ, Stephens JA. Surgical correction of brachycephalic syndrome in dogs: 62 cases (1991-2004). J Am Vet Med Assoc 2007;230:1324. 6. Torrez CV, Hunt GB. Results of surgical correction of abnormalities associated with brachycephalic airway obstruction syndrome in dogs in Australia, J Small Anim Pract 2006:47: 150. 14
VETERINARY SYMPOSIUM 2020 15
VETERINARY SYMPOSIUM 2020 (notes) 16
VETERINARY SYMPOSIUM 2020 Oral Tumours: From Diagnosis to Treatment. What to Expect. Dr. José C. Almansa Ruiz DVM (Hons) MSc (Vet) EVDC Resident, Board Ready Malignant Oral tumours represent 6-7% of all the tumours diagnosed in canine patients; the incidence is lower in cats. Oral neoplasms should be differentiated from inflammatory processes, infection, and developmental or congenital lesions. A variety of odontogenic and non-odontogenic tumours occur in the oral cavity. These neoplasms may appear as ulcerated, non-healing lesions or a more conventional mass-like structure. The pet owner more readily notices lesions when they occur in the rostral aspects of the maxilla or mandible. Encouraging clients to brush their pets teeth will also help for them to “keep an eye” in their pets oral health. Unfortunately, pet owners only generally notice these neoplasms when they are in an advance stage of development. Hence, the important to act quickly when is first presented to the general practitioner. Staging the oral neoplasia: On the initial presentation, a conscious examination of the mass is performed if the patient allows it, although an examination under general anaesthesia is still required as part of the clinical staging of the tumour. Part of this initial assessment of the patient must always include a CBC, biochemistry panel and in older patients a urine analysis. The TNM system is used to stage these lesions (See addendum). During the clinical assessment of the lesion, features like ulceration, mobility, size, location, consistency, are important for the pathologist to give us a more accurate diagnosis. Part of the staging involves evaluation the regional lymph nodes bilaterally. The mandibular lymph nodes are the only regional lymph nodes superficial enough to be palpated, during this process size and mobility must be recorded. Enlargement of the lymph node does not necessarily mean local metastasis, but also could be a reactive lymph node. The absence of mobility may be an indicator of the invasion of the lymph node capsule by the tumour. A study performed by Williams et al (2003) reported on 100 cancer patients undergoing clinical examination of the lymph nodes and lymphadenectomies, reported that 70% of cases with Lymphadenomegaly had metastatic disease and 40% of cases without lymphadenomegaly had metastatic disease (Williams / Packer 2003). 17
VETERINARY SYMPOSIUM 2020 Lymph nodes can also be evaluated using contrast-enhanced CT imaging, one study looked at the diagnostic accuracy of CT for determining metastatic mandibular and medial retropharyngeal lymph nodes in dogs with either nasal or oral cancers reporting a sensitivity of 12.5 and 10.5%, and the specificity was 91.1 and 96.7%, for mandibular and medial retropharyngeal lymph nodes, respectively. Due to the low sensitivity, contrast-enhanced CT imaging is not a reliable tool to predict lymphnode metastasis. Guided ultrasound fine needle aspiration permits sampling of the mandibular, retropharyngeal and parotid lymphocentres; the withdraw of this practice is the possibility of missing microscopic metastatic disease if no gross lesions are present in the sampled lymph nodes. More recent studies have confirmed the lesser reliability of FNA assessing metastasis, with one study reporting 77.2% accuracy in dogs and cats and another reporting an incidence of 72.8% and 85.9% diagnostic samples in dogs and cats, respectively (Ku/Kass 2017 and Amore-Fuster/Cripps 2015). Furthermore, things get a little bit complicated when evaluating metastatic disease in melanocytic tumours due to the difficulty to differentiate melanocytophages from melanocytes in the regional lymphnodes. Billateral lymphadenectomy of the medial retropharyngeal and mandibular lymphocentrums reported an incidence of metastatic disease in 48 canine patients suffering from oral melanoma and oral squamous cell carcinoma of 33% in at least once lymphocentrum (Grimes/Mestrinho 2019). Odenweller et al evaluated metastatic disease in 98 dogs and 10 cats presented with oral and maxillofacial neoplasms; unilateral excisional biopsies were performed, including the parotid lymphocentrum, reporting an overall metastatic rate of 14%. Of the cases with metastatic disease, 26.7% did not involve the mandibular lymphocentrum. Hence, the importance of not to rely only on the palpation, aspiration or biopsy of the mandibular lymphocentrum. To date no clinical studies have reported a correlation between performing unilateral or bilateral lymphadenectomies and the survival times. It is the author’s opinion that a more aggressive treatment can be instated based on a more accurate staging. Imaging can be used to assess the extent of local disease and response to treatment, identify lymph nodes that may have metastatic disease, screen distant organs for possible metastasis, and allow image-guided sampling of suspected neoplastic lesions. Choosing the best imaging technique for a patient depends on several factors including where and what is being imaged, what information is needed, and also sometimes cost of the imaging procedure to decide on a best course of action for an individual patient. Computed tomography is routinely used in maxillofacial surgery to evaluate the invasion of bone and extension into adjacent structures; it also helps determine if a tumour is resectable and helps the surgeon to map the osteotomy sites. These reconstructions are also a great education tool for clients, this way they can “see” what has been planned surgically for their pet and they feel more confident about the procedure. If the mass is not resectable, and radiation therapy is indicated, i.e nasal adenocarcinomas, the CT is extremely important to plan it. The CT scan / radiographs of the thorax should be done using positive pressure ventilation. CT has been found to be significantly more sensitive than thoracic radiographs for detecting 18
VETERINARY SYMPOSIUM 2020 soft tissue nodules. Only 9% of CT-detected pulmonary nodules are identified on thoracic radiographs The lower size threshold is approximately 1 mm to detect pulmonary nodules on CT images and 7–9 mm to reliably detect nodules on radiographs. Some authors recommend abdominal ultrasound as part of the initial work up; the reasoning behind it is that in 3% of oncology patients additional synchronous tumours may be present (Rebhun JAAHA 2010 / Bigio Vet Comp Oncol 2017/ Magestro Vet Comp Oncol. 2017). Obtaining a good biopsy sample is extremely important for the surgical and medical planning of the patient. The mainstay of planning the biopsy sites relies on diagnostic imaging, being the gold standard advanced CT imaging (CT or MRI). A good biopsy must have a representative sample of the most severe, showing more changes area/s of the lesion. To achieve this, the clinician must select the best biopsy technique, the correct sample site and submit the sample correctly. The biopsy sample should always represent the worst part of the mass; this may mean collection of more than one sample. Biopsying healthy tissue next to the lesion for comparison as in skin biopsies is contraindicated. The biopsy tract should not transect a healthy tissue plane as during this procedure neoplastic cells may seed along this tract. It is also advisable to obtain microbiological samples in case the changes seen were related to infection and not to neoplasia. There are two types of biopsy, closed or open, the gold standard in oral and maxillofacial oncology is open biopsies. The decision to perform an excisional biopsy is a complex one. This type of biopsy should be reserved to small pedunculated masses, that their removal would not affect the treatment plan. Incisional biopsies using a 4-6 mm punch biopsies at a minimum depth of 2 mm are recommended to biopsy a soft tissue mass. Once the punch is at the desire depth the punch is tilted in order to “scoop” the sample. These samples should be placed on a clear paper for 1min with the connective tissue facing down on the paper to prevent the sample from curling during fixation and to help orientate the sample. The sample will then be transfer to a container with a volume of fixative 20 times more than the size of the sample to prevent degeneration of the sample. It is the opinion of the author to include bone when possible into the sample to help the pathologist get a more accurate diagnosis. Sometimes the mass to biopsy has a mineralized consistency, in those occasions the use of a chisel and mallet or a michele trephine is indicated to collect a representative sample. Epidemiology of common oral neoplasms: DOGS Oral tumours in dogs represent approximately 5.4 % of all canine tumours. The distribution in South Africa based on a study performed between 2000-2008 reported Osteosarcoma to be the most commonly diagnosed malignant oral neoplasia, followed by malignant melanoma and squamous cell carcinoma. The incidence of 19
VETERINARY SYMPOSIUM 2020 osteosarcoma in the literature is much less, with melanomas, fibrosarcomas and squamous cell carcinomas being the three most common malignant tumours in the oral cavity of dogs. There are several reported risk factors associated to some of these neoplasms. Dogs living in urban industrialised regions are more predisposed to develop tonsillar SCC as opposed to rural environments; this may be due to increased exposure to environmental carcinogens. Canine oral papillomavirus is known to be involved in the development of oral papillomas in dogs. Furthermore, it is thought that there can be progression of viral papillomas to carcinomas in dogs. Lastly, oral osteosarcomas have been reported to develop secondary to exposure to ionizing radiation, a known carcinogen. CATS The proportion of oral tumours is slightly higher with 7.4% - 10.6% of all feline neoplasms. The most common neoplasia is SCC, comprising 68 - 98% of all oral malignant tumours. There are several reported risk factors associated with this neoplasia: • Flea collars had five times increased risk of developing oral SCC • Canned food diet (3.6 times increased risk), • Canned tuna fish diet (> 4-fold increase), • Exposure to household environmental tobacco smoke (2x increase, not significant). Bertone JVIM 2003 • Relationship between oral SCC and exposure to household environmental tobacco smoke, and furthermore implicated p53 as a potential site for carcinogen-related mutation, with cats exposed to smoke 4.5 times more likely to overexpress p53 based on evaluation of tumour biopsy samples, and those exposed for 5 years or longer were 7 times more likely to overexpress p53 (Snyder Vet Path 2004). CANINE ACANTHOMATOUS AMELOBLASTOMA (CAA) CAA is a subtype of ameloblastoma that is very specific of dogs. Although considered a benign lesion that does not metastasize, it has tropism for bone, medular, cortical or alveolar bone, causing osteolysis and mobility of teeth. The term acanthomatous means “thorn like”, referring to an internal sheet of interlocking polygonal epithelial cells reminiscent of the epithelial cells of the stratum spinosum of the skin or oral mucosa. This feature is unique to CAA. En-bloc resection is the gold standard of treatment, and is generally curative. It manifests grossly as a gray to pink, irregular, exophytic, verrucous mucosal mass that arises immediately adjacent to teeth. It is indistinguishable from peripheral odontogenic fibroma (POF) / fibromatous epulis of periodontal ligament origin (FEPLO), squamous cell carcinoma, pyogenic granuloma and gingival hyperplasia; hence when dealing with a patient with gingival enlargement, it is extremely important to send for histopathology all the excised tissue. Approximately 50% of CAA occur in 20
VETERINARY SYMPOSIUM 2020 the rostral mandible, but they can be found anywhere in the jaws. Golden retrievers are over represented in the biggest study to date in CAA (Goldschmitdt et al JVD 2017). The treatment options are en-bloc resection with 1 cm margins, intra-lesional bleomycin injections and radiation therapy. The author discourages radiating these lesions due to the possibility of transforming them into SCC. SCC DOG It is the 2nd most common oral tumour in dogs 24.5%. Can be found in different sites of of the oral cavity, involving the gingiva, tonsil, oral mucosa, lip and palate. There are two different types with very different prognosis: non-tonsillar and tonsillar categories. At histological level in dogs, OSCC can be divided into histologic subtypes that are in many but not all aspects similar to OSCC in humans. These subtypes include well-, moderately, and poorly differentiated conventional SCCs as well as more rare subtypes such as papillary and basaloid SCCs and adenosquamous and spindle cell carcinomas. They generally show a “moth eaten” appearance on intra-oral radiographs. The 1-year survival rate ranges from 84% to 91% and the metastatic rate ranges from 3% to 36% in dogs following surgical resection of OSCCs. The prognosis for dogs with OSCC is generally excellent following radical surgical excision of the tumour via mandibulectomy, maxillectomy, or glossectomy. Mandibular/maxillary SCC: The prognosis reported when aggressive surgical resection (at least 1cm – (2cm better!)) is excellent. These margins must always be evaluated based upon pre-op CT imaging (remains the standard of care – with adjunctive therapy in specific cases). In non-tonsillar OSCC, fewer than 15% of dogs have detectable nodal metastases and fewer than 5% of dogs have radiographic evidence of pulmonary metastasis at the time of diagnosis. The outcomes reported following mandibulectomy or maxillectomy for SCC included MSTs of 3.5 to 19.2 months, a disease-free interval of 26 months, and 1-year survival rates of 57% to 91% (Kosovsky Vet Surg 1991, Schwarz JAAHA 1991, White JSAP 1991, Wallace Vet Surg 1992). However, more recent results for SCC treatment outcomes have been reported and include more optimistic rates, such as a 1-year survival rate of 93.5% for 21 dogs that had undergone curative-intent surgery and an MST of 365 days for dogs > 10 years old (Fulton, J Am Vet Med Assoc 2013). The 1- year survival rate for all dogs that were surgically treated was 93.5%; the 1-year survival rate was 100% for dogs
VETERINARY SYMPOSIUM 2020 Radiation therapy alone has a median survival time of 16-36 months. It is better for smaller lesions – showing longer survival times. (Burk 1996). One year survival in 70% of patients and 30% of recurrence rate. Radiation therapy used post-op after incomplete surgical excision of oral SCC had longer median survival time (2051 days) compared to those with incomplete excision and no radiotherapy (181 days). (Riggs, J Am Vet Med Assoc 2018). Radiation therapy has been considered as an adjunctive therapy to reduce tumour size prior to surgery (Mestrinho, Aust Vet J 2012). Maxillary SCC in 1 dog non-resectable at presentation. Radiotherapy and chemotherapy (carboplatin and doxorubicin) decreased tumour size to allow for surgical resection – free from local disease for 421 days. The use of piroxicam has reported the following results: • Piroxicam alone (0.3mg/kg PO SID) (Schmidt, J Am Vet Med Assoc 2001) – Response rate 17.6%. MST 180d. • Piroxicam and cisplatin (Boria, J Am Vet Med Assoc 2004) 5/ dogs responding to tx –However renal toxicity in 41%! So limited clinical usefulness. • Piroxicam and carboplatin (de Vos, Vet Comp Oncol 2005) – 7 dogs with T3 oral SCC (tumour >4cm) had complete response in 57% with median follow-up time of 534 days. There is a novel treatment published in the literature: Intralesional bleomycin and feline IL-12 DNA combined with translesional electroporation (Reed, Cancer Gene Ther 2010) - 2 dogs with mandibular/maxillary SCC. Both had complete response and tumour free 3 and 5 years later. The second report of this treatment with a slight variation (electroporation and IV bleomycin) in a bigger population (11 dogs) reported complete remission in 8 dogs and partial remission in 2. The recurrence rate was 27.3%. All dogs with tumours less than 1-2cm had complete remission without recurrence. (Simcic, Vet Comp Oncol 2019). Lingual/sublingual SCC: With a metastatic rate of 37.5% (Carpenter JAAHA 1993), it is the second most common lingual tumour in dogs after MM (Dennis, J Am Vet Med Assoc 2006). Females are more at risk in all breeds, with poodles, labs and samoyeds overrepresented. The typical presentation is bilateral symmetrical involvement (61.9%), infiltrating the full thickness of the tongue (52.4%) and involving the rostral two-thirds (85.7%). A very good functional outcome has been reported associated with radical glossectomy in 5 dogs – Subtotal (50% resection) or total glossectomy (100% resection) (Dvorak, J Am Anim Hosp Assoc 2004). Hypersalivation is the most common reported complaint following aggressive resection. Tonsillar SCC: It has a high rate of metastasis, with 98% metastasizing to the regional lymph nodes (via lymphatics) and 63% to more distant anatomic sites (presumably hematogenously). The high rate of metastasis is related to a rich blood supply and 22
VETERINARY SYMPOSIUM 2020 lymphatics draining to ipsilateral and contralateral lymphocentres. There are ten times more common in urban vs rural areas with a median age of 10 years. They range from microscopic primary tumours with advanced metastatic disease to bulky exophytic tumours. Surgical resection followed by radiotherapy (9 Gy once a week for 4 weeks) and carboplatin treatment (300mg/m2) in 5 dogs reported a median survival time of 211 days, with 2 dogs been alive and disease free at 826 and 1628 (Murphy, JSAP 2006). In a multi-centre study of 44 dogs treated with surgery, radiotherapy and/or chemotherapy reported an overall median survival time of 179 days (Mas, JSAP 2011). They concluded that no matter what treatment modality was used the survival time was short, although there were a small number of long-term survivors. Papillary SCC: It is a lesser aggressive variant reported in young dogs, but also can be seen in adult dogs (Nemec, J Comp Pathol 2014). It is a distinct histopathological sub-type of SCC. A Retrospective study of 12 dogs – median age 9 years. They presented as a verrucous pink mass arising from the gingiva of rostral maxilla or mandible. May be associated with papillomavirus? – Although no strong evidence. They are locally aggressive with underlying bone lysis. Respond well to aggressive local surgery and radiotherapy. No reports of metastasis. Often curative. SCC CATS SCC represents 61-64% of all oral tumours in cats. Cats with advanced OSCC presented with metastasis of the mandibular lymphnodes or lung metastasis did not have a shorter MST (Soltero-Rivera JFMS 2014). FOSCC exhibit overexpression of COX-1 and COX-2. A study performed in the UK on feline patients treated by their general practitioners reported an overall median survival time was 44 days (Hayes JSAP 2007). Mandibular/maxillary The maxilla and mandible can equally be affected. Most cats are referred for a non- healing surgical site or “abscess”. There is generally bone enlargement with facial asymmetry, ulceration and difficulty eating. 73.1% had marked osteolysis on radiographs. Cats with oral SCC are typically diagnosed late and the response to therapy is poor. Cats with mandibular swellings in 50% of cases will have a tumour. Sometimes there is no difference on rads between tumour and osteomyelitis. (Kapatkin JAAHA 1991). The MST of any treatment method is 60 days (Gendler JAVMA 2010 and Postorino JAHA 1993). When performing a mandibulectomy combined with radiation or chemo in SCC affecting the mandible, there is a 1 yr survival rate of 51%, 2 yr survival rate of 34%. (Northrup JAAHA 2006). If radiation therapy is used on its own the MST is only 36-97 days (Bregazzi 2001 Vet radio ultrasound). 23
VETERINARY SYMPOSIUM 2020 Lingual/Sublingual and Tonsillar Lingual SCC is locally very aggressive and difficult to treat. There are two growth patterns recognised, a destructive or an irregular proliferative pattern. Fidel et al reported a combined protocol using chemotherapy and radiation therapy comprising 14 fractions of 3.5 Gy given within a 9-day period with the addition of carboplatin given at 90–100 mg/m2 on day 1 and day 4.5. Treatments were twice daily with a 6-hour delay between treatments. Cats with tumours of tonsil origin or cheek responded best to therapy and were long-term survivors with a mean survival of 724 days and the median had not been reached because of continued survival of 4 cats (Fidel JVIM 2011). Oral Malignant Melanoma (OMM) DOGS It is the most common malignant neoplasia in the oral cavity of dogs. The term melanoma is a misnomer, as this lesion is a sarcoma; a synonym will be melanosarcoma. Occurs most frequently in aged patients over 11 years of age. Breeds with highly pigmented oral mucosa (Chow-Chow and Scottish Terrier) seem to be over-represented. The gross appearance of oral melanoma varies from coal black, patchy black and white, pink/red (tumour associated granulation tissue), purple, or white (amelanotic). Melanomas readily invade soft tissues and bone and may be associated with extensive local tissue destruction. Disruption of the dental arcade or pathologic fractures can occur if the melanoma invades the jaw. Mostly gingival but can be labial mucosa, palate, buccal mucosa and tongue. Can metastasise to brain, meninges, pituitary gland, striated muscle, pleura, pericardium, heart, prostate, pancreas, adrenal glands, liver, kidney, spleen, ileum, omentum, mediastinal lymph nodes, thyroid, prostate, salivary gland, stomach, testis and eyes, tonsils. HISTOLOGY There are three main categories based on microscopic features of the predominant cell type including polygonal (epithelioid), spindle and mixed (epithelioid and spindle) cells. Different studies disagree re distribution of types. Dx: A variety of useful antibodies for IHC assays are now available for the diagnosis of canine oral melanoma: S100, Melan A, PNL2 and tyrosinase-related proteins 1 and 2. S100 may be the most sensitive, but it is the least specific of this antibody stains. TREATMENT OPTIONS: Curative Intent Surgery Cornerstone combined with vaccine/chemotherapy or radiation therapy. The case series published by Tuohy et al (JAVMA 2014) analysing 70 patients undergoing curative intent surgery described a median progression-free interval and ST of 508 and 723 days, respectively. Thirty-two (45.7%) dogs had disease progression. Significant associations with PFI or ST were found for administration of adjuvant 24
VETERINARY SYMPOSIUM 2020 therapy, presence of metastatic disease at the time of diagnosis, higher tumor stage (III or IV), and increased tumor size (> 3 cm). Co-adjuvant treatment was associated with a 130% increased hazard of disease progression; the presence of metastasis at the time of diagnosis was associated with a 281% increased hazard of death. A second paper (Boston JAVMA 2014) evaluating the efficacy of systemic therapies after surgical excision of oral melanomas indicated that surgical treatment of oral malignant melanoma in dogs can result in an MST of 346 days, with long-term survival in 29% of cases. Dogs that were treated with surgery alone had an MST of 352 days, and we were not able to detect a survival advantage with any form of postoperative adjuvant therapy. Interestingly this paper reported no difference on MST between marginal resections and wide or radical resections. Xenogeneic DNA vaccination Vaccine (Oncept in the UK) contains plasmid DNA-targeting tyrosinase, a glycoprotein essential for melanin synthesis and demonstrated to be overexpressed in melanomas (Bergman & Wolchok 2008), conflicting results so far but is potentially therapeutic in stage II/III locoregionally controlled disease. Results of Grosenbaug (2011) documented a statistically significant improvement in survival for vaccinates (more than 1075 days) compared to historic controls. Verganti (2017) reported only a disease free interval of 477 days in vaccinated dogs vs 491 for non-vaccinates and a MST of 455 days. In Ottnod’s (2013) study, disease free interval for vaccinates was 171d, and for non vaccinates it was 258 days. In the Verganti (2017) study, effects of vaccine were seen early on (in loading period) but 50% of patients with stages I to III disease died due to local recurrence (with or without regional lymph node involvement; 17·9%) or due to metastatic disease (29·6%) to the lymph nodes, lungs, liver, brain, tonsil and skin which means melanoma vaccine may not be effective in all the patients treated or works only for a limited time. Patients with macroscopic disease had a 44·4% response rate to the vaccine and the MST for dogs with stage IV disease was 178 days. a) Carboplatin: Response rate 28% b) Cisplatin and piroxicam: response rate 18% both drugs nephrotoxic! c) Palliative radiation: MST 7.9 months (prognosis not dependent on stage- they all respond the same) d) Definitive-intent radiation therapy (Proulx 2003) MST 7 months e) Hypofractionated radiation + low-dose cisplatin or carboplatin as a radiation sensitizer- mst 363 days. FIBROSARCOMA DOG It is one of the three most common tumours reported in the oral cavity of dogs. It is locally aggressive with a low rate of metastasis (
VETERINARY SYMPOSIUM 2020 Frazier et al. Vet and Comp. Oncology 2011: A total of 29 dogs were included in this study. The overall survival time (from surgery to tumour related death) reported here was 24.8 months. Seven dogs (24.1%) developed metastasis: three to regional (mandibular) lymph node only, three to lung only and one to both regional lymph node and lung. The median survival time of the seven dogs that developed metastasis was 391 days. Golden Retriever or Golden Retriever mixed breed dogs were more likely to experience local recurrence than other breeds (P = 0.03). The median survival time (MST) of all dogs was 743 days (95% CI 569–1598 days). The 1-and 2-year survival times were 87.7% (95% CI66.5–95.9) and 57.8% (95% CI 31.6–77), respectively. The median survival times of dogs treated with surgery alone or with surgery and radiation therapy were not statistically different (1024 days and 576 days, respectively; P = 0.40). The MST for dogs with complete excision was not statistically different from those with incomplete excision (1598 days versus 576 days, respectively; P = 0.09); Gardner et al VCO 2015. 65 Dogs receiving different therapies: Approach Median survival Notes time (d) Conservative surgery 301 Aggressive surgery (removal of bone), 526 some of these had radiation Palliative intent radiation therapy – 24- 204 30gy Definitive radiation therapy (no sx) – 54- 825 these were all T3 60Gy Chemotherapy (Doxorubicin or Use of chemo didn’t stat sig affect MST Lomustine) No Tx 205 RADIATION AND SURGERY 505 RADIATION (CURATIVE INTENT) AND 575 not stat sig vs palliative and SURGERY surgery Soft tissue sarcomas have been historically considered resistant to radiation therapy, requiring doses above 50 Gy to markedly affect the neoplastic tissue. Although radiation therapy can be used to treat macroscopic disease, it is most efficacious when employed against microscopic disease. 26
VETERINARY SYMPOSIUM 2020 Hi-lo fibrosarcomas: Median age 8yo and 52% were golden retrievers (Ciekot et al JAVMA 1994). Histopath: fibroblasts with abundant collagenous tissue. Recognised as ‘Low grade’ due to • low numbers of fibrocytes, • low mitotic index (0-1 mitotic figues per HPF), • minimal cellular anaplasia, • minimal pleomorphism, • abundant collagenous matrix. • Poor demarkation from surrounding tissue Innocuous histo appearance but these are invasive: invade ST and bone and met to local LN. 72.7% of dogs evaluated found to have underlying bone lysis ‘Fibrosarcoma’ doesn’t distinguish between low grade and high grade. OSTEOSARCOMA DOG It is the most common bone tumor in dogs. Osteosarcomas are divided into appendicular and axial, with 49% of axial osteosarcomas occurring in the mandible or maxilla. Osteosarcomas of the maxillofacial region most often arise from the bone medullary region. Although can also be juxtacortical OSA (Periosteal and parosteal OSA) (Murphy Veterinary Oral and Maxillofacial Pathology 2019). The mean age at diagnosis of canine oral and maxillofacial osteosarcoma is 9–10 years. Seventy three per cent of dogs with maxillary osteosarcoma, and 100% of mandibular osteosarcoma have been reported to weigh more than 20 kg. Mixed-breed dogs, German shepherds, golden retrievers and Labrador retrievers were most commonly presented. Factors such as ionizing radiation, genetics, bone tumour viruses, chemicals, chronic irritation due to fractures repaired by metallic implants, bone infarcts, skeletal diseases or disorders as well as body size and sex are believed to be involved in pathogenesis. While osteosarcoma in general is known to be a disease with rapid local progression and mortality due to early lung metastasis, comparatively, oral and maxillofacial osteosarcoma have been found to progress slower and show lower tendency to metastasize than other axial subtypes. As with osteosarcomas at other locations, clinical signs are caused by the expansive mass and tissue destruction. There are six histologic subtypes of OSA – osteoblastic (osteoblasts predominate), fibroblastic (fibroblast-like spindle cells arranged in patterns reminiscent of fibrosarcoma), chondroblastic (extensive regions of chondroblastic differentiation with chondroid matrix deposition), giant cell (large numbers of intermixed multinucleate cells), telangiectatic (endothelium like sarcoma cells form blood-filled cavities and sinuses reminiscent of hemangiosarcoma), and poorly differentiated OSA (neoplastic cells are anaplastic). Osteoblastic OSA is further subdivided into productive (abundant tumor associated osteoid matrix (TAOM)) or nonproductive (minimal TAOM) (Murphy Veterinary Oral and Maxillofacial Pathology 2019). 27
You can also read